# Discriminator report

## Scenario echo
Human pancreas, with celltype, age, sex, and condition unspecified/null, so the embedding should cover the normal human pancreatic tissue landscape broadly: endocrine islet cells, acinar and ductal epithelium, vascular and lymphatic endothelium, stromal/mural/mesothelial/adipose compartments, resident immune cells, and neural/Schwann-associated cells. There are no notes imposing a special developmental, disease, or pathway emphasis.

## Rating: minor
The blueprint is biologically plausible and broadly complete for human pancreas, with good coverage of major epithelial, endocrine, stromal, vascular, immune, and neural compartments. It still needs targeted refinement around progenitor-state scoping and a few subtype/marker choices before I would call it publishable unchanged.

## Findings

### Minor issues
- **axis:pancreatic_epithelial_progenitor_state / module:pancreatic_epithelial_progenitor** — This axis is framed as a progenitor state in a scenario with no developmental note. The marker set is also a mixture of normal mature-lineage regulators: PDX1 and NKX6-1 mark beta-lineage cells, SOX9/HNF1B/ONECUT1 mark ducts, and PTF1A/RBPJL-related programs mark acinar identity. Even with negatives, it may score ordinary adult epithelial lineages rather than a true progenitor/immature program.
  *Fix:* Either narrow this to an explicitly immature/regenerative epithelial program with stronger progenitor markers and better sibling negatives, or de-emphasize it by renaming/reframing as "immature_epithelial_lineage" and reducing mature-lineage markers that make adult ductal/beta/acinar cells score.

- **axis:neurogenin_endocrine_progenitor_state / module:endocrine_progenitor_neurogenin** — NEUROG3/INSM1 endocrine progenitors are developmentally important but rare/outside most healthy postnatal pancreas samples. With age unspecified, they can be retained, but the axis should be carefully scoped so it does not read as a required adult cell population. The module also includes SOX9 and NEUROD1, which can pull in ductal or differentiated endocrine signal.
  *Fix:* Keep NEUROG3/INSM1/HES6/DLL1/PAX4/NKX2-2 as the core, but reduce generic ductal/differentiated endocrine leakage and make the axis name/state explicitly immature endocrine progenitor-like rather than a normal mature pancreatic compartment.

- **endocrine subtype gated axes** — Most endocrine subtype axes use sibling negatives but omit the enterochromaffin-like module from the beta/alpha/delta/gamma/epsilon negative sets, and the enterochromaffin-like axis omits epsilon as a negative. These rare endocrine states share neuroendocrine processing genes and should be contrasted with all other endocrine siblings for cleaner subtype resolution.
  *Fix:* Add `enterochromaffin_like_endocrine` to the negative modules for the beta, alpha, delta, gamma/PP, and epsilon axes, and add `epsilon_ghrelin_cell` as a negative for `enterochromaffin_like_endocrine_subtype`.

- **module:epsilon_ghrelin_cell** — GHRL and MBOAT4 are plausible epsilon-cell markers, but MLN is more characteristic of gastrointestinal motilin endocrine cells than canonical pancreatic epsilon cells and may create avoidable cross-tissue endocrine signal.
  *Fix:* Replace or supplement MLN with a more pancreas-relevant ghrelin/epsilon or immature endocrine marker; keep GHRL and MBOAT4 as anchors.

- **module:venous_endothelium** — ACKR1 and NR2F2 are plausible venous markers, but SELE and VCAM1 are more activation/inflammation-associated endothelial genes than venous identity markers in a healthy baseline scenario.
  *Fix:* Consider replacing SELE/VCAM1 with more stable venous/venular markers, or split activation only if an endothelial activation state is intentionally represented.

## Out of scope (FYI, not actionable for the Generator)
- The dimensionality is high but defensible for a broad all-cell human pancreas embedding; no deletion is needed solely on dimensionality grounds.
- Rare populations such as neutrophils or erythroid contaminants could appear in some dissociation datasets, but they are not core healthy pancreas compartments and do not require axes here.

## Summary for the next round
Focus on making progenitor-like axes biologically scoped rather than mature-lineage mixtures, tightening endocrine sibling contrasts for rare epsilon/enterochromaffin-like cells, and swapping a few markers that may capture off-scenario activation or gastrointestinal endocrine identity. No existing axis or module requires deletion.
